These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33899625)

  • 1. Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.
    Cao N; Tang H; Tian M; Gong X; Xu Z; Zhou B; Lan C; Chen C; Qu S; Zheng S; Ren H; Fan C; Jose PA; Zeng C; Xia T
    Clin Exp Hypertens; 2021 Oct; 43(7):597-603. PubMed ID: 33899625
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
    Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
    Bhatnagar V; O'Connor DT; Brophy VH; Schork NJ; Richard E; Salem RM; Nievergelt CM; Bakris GL; Middleton JP; Norris KC; Wright J; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS;
    Am J Hypertens; 2009 Mar; 22(3):332-8. PubMed ID: 19119263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics.
    Yang J; Hall JE; Jose PA; Chen K; Zeng C
    Pharmacol Ther; 2022 Nov; 239():108194. PubMed ID: 35487286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
    Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
    Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
    Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and antihypertensive effects of candesartan cilexetil in patients undergoing haemodialysis: an open-label, single-centre study.
    Schulz EG; Bahri S; Schettler V; Popov AF; Hermann M
    Clin Drug Investig; 2009; 29(11):713-9. PubMed ID: 19813774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
    Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
    Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care.
    Edes I;
    Clin Drug Investig; 2009; 29(5):293-304. PubMed ID: 19366271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candesartan cilexetil effectively reduces blood pressure in hypertensive children.
    Franks AM; O'Brien CE; Stowe CD; Wells TG; Gardner SF
    Ann Pharmacother; 2008 Oct; 42(10):1388-95. PubMed ID: 18664605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and tolerability of candesartan cilexetil. Candesartan Study Groups in Japan.
    Ogihara T; Arakawa K
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S27-31; discussion S33-4. PubMed ID: 10076918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of candesartan cilexetil with hydrochlorothiazide on blood pressure and ST-segment depression in patients with arterial hypertension].
    Uen S; Un I; Fimmers R; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2007 Jan; 132(3):81-6. PubMed ID: 17219340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-protein receptor kinase 4 polymorphism and response to antihypertensive therapy.
    Muskalla AM; Suter PM; Saur M; Nowak A; Hersberger M; Krayenbuehl PA
    Clin Chem; 2014 Dec; 60(12):1543-8. PubMed ID: 25301854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of azilsartan versus candesartan on nocturnal blood pressure variation in Japanese patients with essential hypertension.
    Rakugi H; Kario K; Enya K; Igeta M; Ikeda Y
    Blood Press; 2013 Sep; 22 Suppl 1():22-8. PubMed ID: 23885792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.
    Gradman AH; Lewin A; Bowling BT; Tonkon M; Deedwania PC; Kezer AE; Hardison JD; Cushing DJ; Michelson EL
    Heart Dis; 1999; 1(2):52-7. PubMed ID: 11720604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators.
    Asmar R; Lacourcière Y
    J Hypertens; 2000 Nov; 18(11):1683-90. PubMed ID: 11081784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of 10-mg azilsartan compared with 8-mg candesartan cilexetil in Japanese patients with hypertension: a randomized crossover non-inferiority trial.
    Takahara M; Shiraiwa T; Shindo M; Arai A; Kusuda Y; Katakami N; Kaneto H; Matsuoka TA; Shimomura I
    Hypertens Res; 2014 Sep; 37(9):852-7. PubMed ID: 24739538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.